Syapse Precision Medicine

by Syapse  · Based in United States →
Hematology Oncology
Website
Claim this tool
Is this the maker? Claim the company →

Overview

Syapse Precision Medicine is an AI tool designed to support the clinical implementation of precision oncology. It is primarily for oncologists and healthcare systems, including academic and community cancer centers. [3, 7, 9]

  • What it does: The platform integrates clinical and genomic data to provide insights at the point of care. [3, 8, 9] It aggregates various patient data, including health history, medical records, cancer status, lab results, radiology, pathology, molecular, genomic, and treatment data. [11] Syapse also functions as a real-world evidence company, partnering with health systems, life sciences companies, and regulators. [1]
  • Who it is for: The tool is intended for healthcare providers, specifically oncologists, within academic and community health systems. [3, 7, 9] It supports the entire cancer care journey, from prevention and diagnosis to treatment and survivorship. [9]
  • How it fits a clinical or practice workflow: Syapse Precision Medicine integrates with existing electronic medical record (EMR) systems, allowing oncologists to access the platform within their clinical workflow. [9, 11] It facilitates decision support by enabling clinicians to review cases, track outcomes, and participate in virtual tumor boards. [4, 8] The platform also assists in identifying patients eligible for clinical trials and streamlining drug procurement. [4, 7]
  • Notable capabilities: Key capabilities include clinical and genomic data integration, decision support, care coordination, and quality improvement. [3] It enables the use of real-world evidence to inform treatment decisions and supports the development of observational research analytics. [1, 7, 12] Syapse also offers applications for NGS diagnostic informatics, including Syapse Oncology, Syapse MDx, and Syapse PGx, which cover the workflow from patient sample to physician’s report. [2]

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

What Physicians Need to Know

Key Capabilities
Syapse Precision Medicine Platform is a comprehensive software suite for clinical implementation of oncology precision medicine, offering clinical and genomic data integration, decision support, care coordination, and quality improvement at the point of care. It enables Molecular Tumor Board case review, streamlines drug procurement, and facilitates patient matching for clinical trials. The platform also provides a unified, longitudinal view of patient data, integrating clinical, pathology, radiology, treatment, and molecular data from various siloed systems. Advanced features include real-world evidence generation and analytics, workflow automation, customizable dashboards, and machine learning for patient identification and metastasis classification.
Clinical Utility
The platform improves clinical outcomes for cancer patients, with studies demonstrating a doubling of progression-free survival for advanced cancer patients without increasing costs. It empowers oncologists with genomic data-informed treatment decisions and increases drug procurement rates for targeted therapies. Syapse aids in accelerating molecularly targeted treatments to market and provides robust insights and decision-making tools for healthcare providers. It also supports value-based care models by helping health systems understand the health economics and outcomes impact of precision medicine.
Integration Options
Syapse integrates clinical, genomic, and molecular data from electronic health records, labs, and pharmacies. It has established partnerships with major health systems, life sciences companies (e.g., Amgen, Roche, Pfizer, Merck), and genomics technology providers (e.g., Illumina, PierianDx). The platform also integrates with organizations like the National Comprehensive Cancer Network (NCCN) for biomarker data and Medidata for clinical trial design and patient identification. Syapse was recently acquired by N-Power Medicine to further enhance its oncology research network and clinical trial processes.
Compliance Status
While specific certifications are not publicly detailed, Syapse lists 'Compliance Tracking' and 'Data Security' as key features. Given its handling of sensitive patient data and partnerships with major healthcare organizations, it is expected to adhere to relevant healthcare data privacy and security regulations such as HIPAA.
Pricing Model
Syapse's pricing is not publicly disclosed and is typically provided upon request based on specific requirements, suggesting an enterprise-level or subscription-based model. Some product development has been funded through collaborations with partners like Roche.
User Experience
The platform is designed with user-centered processes for oncologists, researchers, and clinical staff, providing a unified and longitudinal view of patient data to eliminate searching across siloed systems. It aims to empower physicians with confidence in treatment decisions and simplifies complex information through clear data visualizations.
Implementation Complexity
Implementing Syapse involves a comprehensive approach to precision oncology services, including tumor sequencing, Molecular Tumor Board review, and drug procurement. While it automates cumbersome workflows, it requires a different approach to information management than traditional EHR systems. However, health systems like Intermountain Healthcare have successfully scaled their precision medicine programs using Syapse.
Evidence Base
Syapse has a strong evidence base, including studies demonstrating improved progression-free survival and cost-effectiveness in advanced cancer patients. It actively collaborates with pharmaceutical companies to develop real-world evidence and assess treatment outcomes. The platform utilizes real-world data and machine learning for patient identification and metastasis classification, and is focused on developing a 'learning health system' to continuously improve care.
Physician Tip

Leverage Syapse's integrated patient record for a holistic view of clinical and genomic data to inform personalized treatment plans. Utilize the Molecular Tumor Board support and clinical trial matching capabilities to ensure patients have access to the most appropriate and advanced care options. The real-world evidence generated by the platform can provide valuable insights into treatment effectiveness and cost-efficiency, supporting value-based care initiatives.

Syapse is designed for extensive integration, connecting with EHRs, various labs, and pharmacies to consolidate patient data. Its robust network of partnerships with life sciences companies and genomics providers further enhances its utility by facilitating real-world evidence generation and clinical trial recruitment. The recent acquisition by N-Power Medicine indicates a continued focus on integrating clinical research into routine oncology practice.

Details

Category Oncology AI
Pricing Unknown
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status Unknown AI-estimated
Integrations
EHR Not specified
Specialties Hematology, Oncology

What the Web Says

Syapse Precision Medicine is generally viewed as a valuable platform for integrating genomic and clinical data to support precision oncology. It aims to standardize data, facilitate clinical trials, and provide actionable insights to physicians. While praised for its potential to improve patient outcomes and research, some users note challenges with implementation and data integration complexities.

Overall: Positive

Strengths

  • Integrates genomic and clinical data effectively for precision oncology.
  • Supports clinical trial matching and patient enrollment.
  • Provides actionable insights for treatment decisions.
  • Aids in standardizing complex healthcare data.
  • Potential to improve patient outcomes in cancer care.
  • Facilitates research and real-world evidence generation.

Limitations

  • Implementation can be complex and time-consuming.
  • Data integration with existing hospital systems can be challenging.
  • Requires significant institutional commitment and resources.
  • User interface can have a learning curve for some.
  • Cost of implementation and ongoing maintenance can be high.
  • Reliance on data quality from various sources.

Based on reviews from: G2, Capterra, Healthcare IT News, Physician reviews (various medical forums/articles), Syapse official website (for stated benefits/features)

Last updated: 2026-07-22

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Syapse Precision Medicine

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for Syapse Precision Medicine.

View all on YouTube

No FAQs available yet for this tool.

Related Tools

FAITH project (Fatigue Therapy – AI-supported Diagnosis and Therapy of Tumour-associated Fatigue Syndrome)
Fimo Health GmbH (Consortium Leader)
Mental & Behavioral Health AI
The FAITH project is developing an AI-based solution for the diagnosis and therapy of tumor-associated fatigue syndrome in cancer patients. It uses wearable sensors, a smartphone app, and artificial intelligence to provide individualized therapy recommendations and monitor mental health.
AI-based support system for skin cancer diagnostics
German Cancer Research Center (DKFZ)
Clinical Decision Support & Reference
Scientists at the German Cancer Research Center have developed an AI-based support system for skin cancer diagnostics that explains its decisions, increasing doctors' confidence in both the AI and their own diagnoses.
eyonis® LCS
Median Technologies
Oncology AI
eyonis® LCS is an FDA 510(k) cleared AI/machine learning-powered software for the detection and diagnosis of lung cancer, helping clinicians detect and characterize suspicious parenchymal pulmonary nodules earlier on low-dose CT scans.
Lumea Digital Pathology
Lumea
Clinical Decision Support & Reference
Lumea is a specialty-specific digital pathology platform that covers the entire diagnostic workflow, from biopsy to final report, and integrates AI tools from partners like Paige and Mindpeak.
Azra AI
Azra AI
Clinical Decision Support & Reference
Azra AI is an AI platform that swiftly analyzes, identifies, and classifies cancer patients, triaging those needing therapy and follow-up to enhance oncology care. It is deployed at more than 1,500 sites and integrated with leading EHRs.
Custom subscription model
Trial Library
Trial Library
Drug Discovery & Research
Trial Library's AI-native platform is embedded in community oncology practices to identify eligible patients for oncology clinical trials. It integrates clinical trials into routine care, activating providers, identifying eligible patients, and navigating them through the trial lifecycle across health systems, biopharma, and payers.

See all Oncology AI tools →

Suggest an Edit → | Last Verified: 2026-04-22 | First Added: 2026-04-22

Investors who backed Syapse Precision Medicine

Funded through the company that built this tool.

Koa Labs
VC T3
Cambridge, United States
$250k-$1M
Koa Labs is a small early-stage investment platform with limited public information about fund size, partner team, and detailed thesis. Public footprint…
AI/ML in Healthcare Care Delivery / Tech-Enabled Services
AI Tool Finder
AI-powered search. Results may not be comprehensive.